Tertiary 2-Haloethylamine Derivatives of the Muscarinic Agent McN-A-343, [4-[[N-(3-Chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium Chloride

Journal of Medicinal Chemistry

Volumn 33, Issue 1, 1990, Pages 281-286

  Ringdahl, Björn ^a   Mellin, Charlotta ^a   Ehlert, Frederick J ^b   Roch, Margareth ^c   Rice, Kathleen M ^c   Jenden, Donald J ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 CHLOROPHENYLCARBAMIC ACID 4 [(2 BROMOETHYL)METHYLAMINO] 2 BUTYNYL ESTER; 3 CHLOROPHENYLCARBAMIC ACID 4 [(2 CHLOROETHYL)METHYLAMINO] 2 BUTYNYL ESTER; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM DERIVATIVE; MUSCARINIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT;

ALKYLATION; ALKYNES; ANIMAL; BLOOD PRESSURE; CARBAMATES; CHEMISTRY; CYCLIZATION; GUINEA PIGS; ILEUM; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOLECULAR STRUCTURE; MUSCLE CONTRACTION; QUINUCLIDINYL BENZILATE; RATS; RECEPTORS, MUSCARINIC; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025056723     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00163a046     Document Type: Article

References (21)

1. Roszkowski, A. P. J. Pharmacol. Exp. Ther. 1961, 132, 156.
2. Haefely, W. E. Handb. Exp. Pharmacol. 1980, 53, 313.
3. Roszkowski, A. P.; Yelnosky, J. J. Pharmacol. Exp. Ther. 1967, 156, 238.
4. Nelson, W. L.; Freeman, D. S.; Wilkinson, P. D.; Vincenzi, F. F. J. Med. Chem. 1973, 16, 506.
5. Nelson, W. L.; Freeman, D. S.; Vincenzi, F. F. J. Med. Chem. 1976, 19, 153.
6. Lambrecht, G.; Moser, U.; Mutschler, E.; Walther, G; Wess, J. J. Med. Chem. 1986, 29, 1309.
7. Mellin, C.; Vargas, H. M.; Ringdahl, B. J. Med. Chem. 1989, 32, 1590.
8. Caulfield, M.; Straughan, D. Trends Neurosci. 1983, 6, 73.
9. Mash, D. C.; Flynn, D. D.; Potter, L. T. Science 1985, 228, 1115.
10. Young, J. M. J. Pharm. Pharmacol. 1982, 34, 162.
11. Cohen, S. A.; Neumeyer, J. L. J. Med. Chem. 1983, 26, 1348.
12. Hall, A. W.; Taylor, R. J. K.; Simmonds, S. H.; Strange, P. G. J. Med. Chem. 1987, 30, 1879.
13. Ringdahl, B.; Resul, B.; Ehlert, F. J.; Jenden, D. J.; Dahlbom, R. Mol. Pharmacol. 1984, 26, 170.
14. Ringdahl, B.; Jenden, D. J. J. Med. Chem. 1987, 30, 852.
15. Ringdahl, B.; Roch, M.; Katz, E. D.; Frankland, M. C. J. Med. Chem. 1989, 32, 659.
16. Ringdahl, B.; Jenden, D. J. Life Sci. 1983, 32, 2401.
17. Wilffert, B.; Davidesko, D.; Timmermans, P. B. M. W. M.; van Zweiten, P. A. J. Pharmacol. Exp. Ther. 1983, 226, 855.
18. Mesplie, Y.; Bergon, M.; Calmon, J.-P. J. Heterocycl. Chem. 1984, 21, 985.
19. Ringdahl, B.; Jenden, D. J. J. Pharmacol. Exp. Ther. 1987, 240, 370.
20. Ehlert, F. J.; Jenden, D. J. Mol. Pharmacol. 1985, 28, 107.
21. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. J. Biol. Chem. 1951, 193, 265.